Head and Neck Oncology Journal Club logo

Head and Neck Oncology Journal Club

Archives
Systemic Treatment of Thyroid Cancer: the new ASCO guideline
May 21, 2026
This week's episode walks through the new ASCO guideline on systemic therapy for thyroid cancer (Saba et al., JCO, April 2026) — 32 recommendations across...

AJCC/UICC TNM9 for HPV+ Oropharyngeal Cancer
April 10, 2026
New in Annals of Surgical Oncology TNM8 for HPV+ oropharyngeal cancer had a structural problem: over 60% of patients were cN1, and over 80% were pathological...

Remote-Access Thyroidectomy and Parathyroidectomy - 2025 International Consensus Statement
March 29, 2026
New in THYROID Remote-access thyroid and parathyroid surgery has been performed for over 20 years. Four approaches are now in regular use worldwide. Until...

Can Split-Course RT Replace Standard Fractionation in Frail Older HNSCC Patients?
March 8, 2026
New in The Lancet Healthy Longevity For decades, radiation oncologists have been delivering hypofractionated split-course radiotherapy to frail older...

Does every sporadic MTC need a total thyroidectomy?
March 4, 2026
Does Every Sporadic MTC Need a Total Thyroidectomy? New in JAMA Otolaryngology - Head & Neck Surgery Total thyroidectomy has been the default for medullary...

RCT: Routine vs PTH-Guided Calcium Supplementation After Total Thyroidectomy
February 22, 2026
Postoperative hypocalcemia is the most common complication after total thyroidectomy. For years, two camps have debated the best prevention strategy:...

Proposed TNM-9 Classification for Salivary Gland Carcinoma
February 14, 2026
Huang SH, Cotler J, Palis B, Seethala RR, et al. Proposed Version Nine of the AJCC and UICC TNM Classification for Salivary Gland Carcinoma. JAMA...

DELII Trial: Ultra-Low-Dose Nivolumab in Relapsed Refractory Solid Tumors
February 8, 2026
Noronha V, Patil V, Menon N, et al. Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized...

Proton vs Photon Radiotherapy for Oropharyngeal Cancer
February 1, 2026
Frank SJ, Busse PM, et al. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-...

The IoN Trial — Can Low-Risk Thyroid Cancer Skip Radioiodine?
January 26, 2026
Mallick U, Newbold K, et al. Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK...

European TORS Guidelines for Head and Neck Cancer
January 18, 2026
A landmark consensus establishing standardized indications, contraindications, and perioperative care for transoral robotic surgery Welcome back to the Head...

Alcohol and Buccal Mucosa Cancer:No Safe Levels
January 11, 2026
This week, we examine a landmark multicentric case-control study from India that fundamentally challenges the concept of "safe" alcohol consumption for...

NIVOPOST-OP: First Breakthrough in High-Risk Resected HNSCC in 20 Years
January 3, 2026
NIVOPOST-OP: First Breakthrough in High-Risk Resected HNSCC in 20 Years For over 20 years, the standard of care for high-risk resected head and neck cancer...

Could Immunotherapy Change How We Manage the cN0 Neck?
December 3, 2025
Journal: Int J Oral Maxillofac Surg (2025) Study Type: Review Article Authors: Bu LL, Xu ZY, Kuo ZY, Wei LY, Liu B, Jia J Institution: Wuhan University,...

www.linkedin.com
Powered by Buttondown, the easiest way to start and grow your newsletter.